• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of Vaccination Effect by Hsp 70-Malaria Antigen Peptide Complex

Research Project

Project/Area Number 06670259
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field 寄生虫学(含医用動物学)
Research InstitutionOkayama University

Principal Investigator

UDONO Heiichiro  Okayama University Medical School, Assistant Professor., 医学部, 助手 (50260659)

Co-Investigator(Kenkyū-buntansha) ONO Toshiro  Okayama University Medical School, Assistant Professor., 医学部, 助手 (50185641)
Project Period (FY) 1994 – 1995
Project Status Completed (Fiscal Year 1995)
Budget Amount *help
¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 1995: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1994: ¥1,200,000 (Direct Cost: ¥1,200,000)
KeywordsMice Malaria / Plasmodium berghei / CS protein / Killer T cell / Heat Shock Protein 70 / マラリア / P.bergfei / 熱ショック蛋白 / CTLエピトープ / ワクチン
Research Abstract

For establishment of preerythrocytic vaccination model against mice malaria Plasmodium berghei, we tried to induce cellular immunity to CS protein of plasmodium berghei.
1.Cytotoxic T cell epitope, NDDSYIPSAEKI which is recognized in a context with H-2 K^d by CTL lines against CS protein of Plasmodium berghei was biochemically synthesized. This 12mer peptide and heat shock protein 70 were mixed and incubated for 1 hour ar 37゚C for making the hsp70-peptide.
2.BALB/c mice were immunized with 10mg (per mouse) of this hsp70-peptide complex twice at a week interval and spleens were removed and suspended cells were incubated with the peptide for five days in 5% CO_2,37゚C.Cytotoxic activity of the effector cells was assayd with ^<51>Cr labelled P815 target cells pulsed with the peptide.
3.By in vitro stimulation with the different dose, 1 x 10^<-4>,1 x 10^<-5>,1 x 10^<-6>,1 x 10^<-7>,1 x 10^<-8> mol of the peptide, optimal concentrations of the peptide were identified as 1 x 10^<-6> and 1 x 10^<-7> mol for induction of primary CTLs.
4.Incubation of spleen cells with the peptide in the presence of IL2 revealed no mounting effect of cytotoxic activity was observed, rather IL2 decreased the activity.
5.Since repeated stimulation of effector cells with the peptide apparently increased the cytolytic activity, establishment of long term cultured cell lines were on going now.

Report

(3 results)
  • 1995 Annual Research Report   Final Research Report Summary
  • 1994 Annual Research Report
  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] 鵜殿 平一郎: "腫瘍細胞熱ショック蛋白の抗腫瘍効果における役割-腫瘍拒絶抗原としての熱ショック蛋白-" 別冊 医学の歩み 免疫疾患-state of arts-. 239-242 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] 鵜殿 平一郎: "熱ショック蛋白と癌免疫" 血液・免疫・腫瘍. 1. 36-40 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Udono H.,et al.: "Heat shock proteins in cancer immunotherapy." Medical Intelligence Unit.in press.(1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Udono, H.: "A role of tumor derived heat shock proteins against cancer.-Heat shock proteins as tumor rejection antigens." IGAKU no AYUMI Immunological disease-state of arts-. 239-242 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Udono, H.: "Heat shock protein and cancer immunology" Blood Immunity Cancer. 1. 36-40 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Udono, H., et al.: "Heat shock proteins in cancer immunotherapy." Medical Intelligence Unit.(in press). (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] 鵜殿 平一郎: "腫瘍細胞熱ショック蛋白の抗腫瘍効果における役割-腫瘍拒絶抗原としての熱ショック蛋白" 別冊 医学のあゆみ 免疫疾患-state of arts-. 239-242 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] 鵜殿 平一郎: "熱ショック蛋白と癌免疫" 血液・免疫・腫瘍. 1. 36-40 (1996)

    • Related Report
      1995 Annual Research Report
  • [Publications] Udono H.,et al.: "Heat shock proteins in cancer immunotherapy." Medical Intelligence Unit.(in press.). (1996)

    • Related Report
      1995 Annual Research Report
  • [Publications] Srivastava P.K.,Udono H.: "Heat shock protein-peptide complexes in cancer immunotherapy." Curr.Opin.Immunol.6. 728-732 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Udono,H.,Srivastava,P.K.: "Comparison of Tumor-specific immunogenicities of stress-induced proteins gp96,hsp90,and hap 70." J.Immunol.152. 5398-5403 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Udono,H.et al.: "Cellular requirements for tumor-specific immunity elicited by heat shock proteins:Tumor rejection antigen gp96 primes CD8^+T cells in vivo." Proc.Natl.Acad.Sci.USA. 91. 3077-3081 (1994)

    • Related Report
      1994 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi